...
首页> 外文期刊>Spine >Injection therapy for subacute and chronic low back pain: an updated Cochrane review.
【24h】

Injection therapy for subacute and chronic low back pain: an updated Cochrane review.

机译:亚急性和慢性下腰痛的注射疗法:最新的Cochrane评论。

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY DESIGN: A systematic review of randomized controlled trials (RCTs). OBJECTIVE: To determine if injection therapy is more effective than placebo or other treatments for patients with subacute or chronic low back pain. SUMMARY OF BACKGROUND DATA: The effectiveness of injection therapy for low back pain is still debatable. Heterogeneity of target tissue, pharmacological agent, and dosage, generally found in RCTs, point to the need for clinically valid comparisons in a literature synthesis. METHODS: We updated the search of the earlier systematic review and searched the Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE databases up to March 2007 for relevant trials reported in English, French, German, Dutch, and Nordic languages. We also screened references from trials identified. RCTs on the effects of injection therapy involving epidural, facet, or local sites for subacute or chronic low back pain were included. Studies that compared the effects of intradiscal injections, prolotherapy, or ozone therapy with other treatments were excluded unless injection therapy with another pharmaceutical agent (no placebo treatment) was part of one of the treatment arms. Studies about injections in sacroiliac joints and studies evaluating the effects of epidural steroids for radicular pain were also excluded. RESULTS: Eighteen trials (1179 participants) were included in this review. The injection sites varied from epidural sites and facet joints (i.e. intra-articular injections, peri-articular injections and nerve blocks) to local sites (i.e. tender-and trigger points). The drugs that were studied consisted of corticosteroids, local anesthetics, and a variety of other drugs. The methodologic quality of the trials was limited with 10 of 18 trials rated as having a high methodologic quality. Statistical pooling was not possible because of clinical heterogeneity in the trials. Overall, the results indicated that there is no strong evidence for or against the use of any type of injection therapy. CONCLUSION: There is insufficient evidence to support the use of injection therapy in subacute and chronic low-back pain. However, it cannot be ruled out that specific subgroups of patients may respond to a specific type of injection therapy.
机译:研究设计:随机对照试验(RCT)的系统评价。目的:确定对于亚急性或慢性下腰痛患者,注射疗法是否比安慰剂或其他疗法更有效。背景数据概述:腰背痛的注射疗法的有效性尚有争议。通常在RCT中发现的靶组织,药理学药物和剂量的异质性表明需要在文献综合中进行临床上有效的比较。方法:我们更新了较早的系统评价的搜索结果,并搜索了截至2007年3月的Cochrane对照试验中央注册簿,MEDLINE和EMBASE数据库,以英语,法语,德语,荷兰语和北欧语报道的相关试验。我们还从确定的试验中筛选了参考文献。包括涉及硬膜外,小平面或局部部位的亚急性或慢性下腰痛的注射治疗效果的随机对照试验。除非将另一种药物的注射疗法(无安慰剂疗法)作为治疗方案的一部分,否则排除将椎间盘内注射,prolotherapy或臭氧疗法与其他疗法的效果进行比较的研究。 excluded关节注射的研究和硬膜外类固醇对神经痛的疗效评估研究也被排除在外。结果:18项试验(1179名参与者)被纳入本评价。注射部位从硬膜外部位和小关节(即关节内注射,关节周围注射和神经阻滞)到局部部位(即压痛点和触发点)不等。研究的药物包括皮质类固醇,局部麻醉药和各种其他药物。试验的方法学质量受到18种具有较高方法学质量的试验中的10种的限制。由于试验中的临床异质性,无法进行统计汇总。总体而言,结果表明,没有强有力的证据支持或反对使用任何类型的注射疗法。结论:没有足够的证据支持在亚急性和慢性下腰痛中使用注射疗法。但是,不能排除特定的患者亚组可能对特定类型的注射疗法有反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号